Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 6/20 | 0.38 |
| ▸ | HTR2A | P28223 | 5/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.35 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.35 |
| ▸ | CCR5 | P51681 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5259569 | 0.88 | POLB (0.42) | AOC3LMNAHRH1HTR2ASIGMAR1 | |
| SCHEMBL1263573 | 0.86 | AOC3 (0.48) | AOC3LMNAESR1ESR2HRH1 | |
| SCHEMBL8824341 | 0.86 | SIGMAR1 (0.42) | HTR2ASIGMAR1OPRM1OPRD1OPRK1 | |
| SCHEMBL3375650 | 0.85 | AOC3 (0.42) | AOC3LMNAESR1ESR2HRH1 | |
| SCHEMBL7469930 | 0.84 | NR1I2 (0.44) | HTR2ASIGMAR1OPRM1OPRD1OPRK1 | |
| SCHEMBL5563476 | 0.84 | NR1I2 (0.44) | HTR2ASIGMAR1OPRM1OPRD1OPRK1 | |
| SCHEMBL2761416 | 0.84 | NR1I2 (0.44) | HTR2ASIGMAR1OPRM1OPRD1OPRK1 | |
| SCHEMBL7643903 | 0.84 | NR1I2 (0.44) | HTR2ASIGMAR1OPRM1OPRD1OPRK1 | |
| SCHEMBL28188782 | 0.84 | NR1I2 (0.44) | HTR2ASIGMAR1OPRM1OPRD1OPRK1 | |
| SCHEMBL28188186 | 0.84 | NR1I2 (0.44) | HTR2ASIGMAR1OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 369 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1738829-B | New 2',5'-oligoadenylic acid analog | SANKYO CO | 2012-11-28 | — | — | CN | claimed |
| CN-108211422-B | Device and method for reducing caprolactam in benzene extraction raffinate | 阳煤集团太原化工新材料有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117916589-A | Analytical method for evaluating purity of indigoid | 阿奇维生命科学公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-113710637-B | Preparation method of biaryl phosphine | 日本化学工业株式会社 | 2023-10-24 | — | — | CN | disclosed |
| CN-111655708-B | 2, 3-biphosphinopyrazine derivative, process for producing the same, complex compound, catalyst, and process for producing organoboron compound | 日本化学工业株式会社 | 2023-08-25 | — | — | CN | disclosed |
| US-11718758-B2 | Aqueous dispersion of colored particles | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2023-08-08 | — | — | US | disclosed |
| EP-3725854-B1 | COLORED PARTICLE AQUEOUS DISPERSION | MITSUBISHI PENCIL CO (JP) | 2023-07-05 | — | — | EP | disclosed |
| CN-111465662-B | Aqueous dispersion of coloured particles | 三菱铅笔株式会社 | 2023-05-26 | — | — | CN | disclosed |
| US-20220402875-A1 | S1P3 Antagonists | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 2022-12-22 | — | — | US | disclosed |
| CN-111032668-B | Optically active 2,3-bisphosphinylpyrazine derivative, process for producing the same, transition metal complex, and process for producing organoboron compound | 日本化学工业株式会社 | 2022-10-14 | — | — | CN | disclosed |
| CN-86102877-A | The method for preparing bicyclic pyrazolidinones | — | 1986-10-29 | — | — | CN | disclosed |
| CN-86103619-A | The preparation method of the bicyclic pyrazolidinones that 7-replaces | — | 1986-10-29 | — | — | CN | disclosed |
| US-4481276-A | ARGON LASER | FUJI PHOTO FILM CO., LTD. (JP) | 1984-11-06 | — | — | US | disclosed |
| EP-0109291-A1 | Photopolymerizable composition | FUJI PHOTO FILM CO., LTD. (JP) | 1984-05-23 | — | — | EP | disclosed |
| US-4399211-A | ACRYLIC OLIGOESTER, DIBASIC ACID, POLYOL AND PROMOTER | FUJI PHOTO FILM CO., LTD. (JP) | 1983-08-16 | — | — | US | disclosed |
| US-4367280-A | AROMATIC CARBONYL COMPOUND AND P-DIALKYLAMINO AROMATIC CARBONYL COMPOUND COMBINATION POLYMERIZATION INITIATOR | FUJI PHOTO FILM CO., LTD. (JP) | 1983-01-04 | — | — | US | disclosed |
| US-4290870-A | 5-ISOXOLONE, AROMATIC CARBONYL, DIALKYLAMINO AROMATIC CARBONYL OR | FUJI PHOTO FILM CO., LTD. (JP) | 1981-09-22 | — | — | US | disclosed |
| US-4259432-A | HIGH SENSITIVITY TO ULTRAVIOLET RADIATION AND ARGON LASER RAYS | FUJI PHOTO FILM CO., LTD. (JP) | 1981-03-31 | — | — | US | disclosed |
| US-4224225-A | PHOTOPOLYMERIZATION INITIATOR | FUJI PHOTO FILM CO., LTD. (JP) | 1980-09-23 | — | — | US | disclosed |
| US-4148658-A | BENZOYLMETHYLENE-BENSOTHIAZOLYIDEND-THIAZOLIDONE COMPOUND, AMINE, AND AMINOARYLCARBONYL COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1979-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220402875-A1 | S1P3 Antagonists | S1PR3, S1PR5, S1PR1 | AOC3 1261/4885LMNA 1938/4885ESR1 1467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.